PROVIDENCE, R.I. (CN) - CVS Pharmacy demands $100 million from three generic drugmakers, claiming K-V Pharmaceutical, Ethex Corp., and Nesher Pharmaceuticals abruptly cut off supplies at the end of 2008, due to their "flawed manufacturing processes" that led to recalls and a temporary FDA ban "on further manufacture of generic drugs."
The CVS Pharmacy chain says it's one of the biggest purchasers of generic drugs in the nation, and relied on defendants' assurances that they could supply it with generics, including Metoprolol Succinate Extended Release tablets, a blood pressure drug.
CVS said it had to turn to alternate suppliers, which charged "substantially increased prices." It claims it suffered more than $100 million in damages.
CVS is represented by Paul Dwyer Jr. with Edwards Angell Palmer & Dodge.
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.
Additional Reads
-
FDA approves over-the-counter Narcan. Here's what it means March 29, 2023 -
-
For role in opioid crisis, drug exec sentenced to prison March 8, 2023 -
